p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers

Oncogene

Volumn 25, Issue 16, 2006, Pages 2318-2327

  Zhang, D W ^a   Jeang, K T ^b   Lee, C G L ^a,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

5 UTR; Diubiquitin; FAT10; p53; Promoter

Indexed keywords

CYTOKINE; PROTEIN FAT10; PROTEIN P53; SMALL INTERFERING RNA; UBIQUITIN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; BINDING SITE; CANCER PATIENT; CARCINOGENESIS; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; FAT10 GENE; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIVER CELL CARCINOMA; MITOSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN TARGETING; TRANSCRIPTION INITIATION SITE; WILD TYPE;

5' UNTRANSLATED REGIONS; BASE SEQUENCE; BINDING SITES; CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; CELL LINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINS; UP-REGULATION;

EID: 33646163921     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209220     Document Type: Article

References (41)

1. Aguiar J, Santurlidis S, Nowok J, Alexander C, Rudnicki D, Gispert S et al. (1999). Biochem Biophys Res Commun 254: 315-318.
2. Bates EE, Ravel O, Dieu MC, Ho S, Guret C, Bridon JM et al. (1997). Eur J Immunol 27: 2471-2477.
3. Boehm U, Klamp T, Groot M, Howard JC. (1997). Annu Rev Immunol 15: 749-795.
4. Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M. (1990). Proc Natl Acad Sci USA 87: 1973-1977.
5. Brummelkamp TR, Bernards R, Agami R. (2002). Science 296: 550-553.
6. Chun AC, Jin DY. (2003). J Biol Chem 278: 37439-37450.
7. Clark IM, Rowan AD, Edwards DR, Bech-Hansen T, Mann DA, Bahr MJ et al. (1997). Biochem J 324(Part 2): 611-617.
8. Dokmanovic M, Chang BD, Fang J, Roninson IB. (2002). Cancer Biol Ther 1: 24-27.
9. el-Deiry WS. (1998). Semin Cancer Biol 8: 345-357.
10. Fan W, Cai W, Parimoo S, Schwarz DC, Lennon GG, Weissman SM. (1996). Immunogenetics 44: 97-103.
11. Farmer G, Colgan J, Nakatani Y, Manley JL, Prives C. (1996). Mol Cell Biol 16: 4295-4304.
12. Haupt Y, Robles AI, Prives C, Rotter V. (2002). Oncogene 21: 8223-8231.
13. Hernando E, Nahle Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M et al. (2004). Nature 430: 797-802.
14. Ho J, Benchimol S. (2003). Cell Death Differ 10: 404-408.
15. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. (2002). J Biol Chem 277: 3247-3257.
16. Innocente SA, Abrahamson JL, Cogswell JP, Lee JM. (1999). Proc Natl Acad Sci USA 96: 2147-2152.
17. Jentsch S, Pyrowolakis G. (2000). Trends Cell Biol 10: 335-342.
18. Jesenberger V, Jentsch S. (2002). Nat Rev Mol Cell Biol 3: 112-121.
19. Kumanovics A, Takada T, Lindahl KF. (2003). Annu Rev Immunol 21: 629-657.
20. Lane DP. (1992). Nature 358: 15-16.
21. Lee CG, Ramachandra M, Jeang KT, Martin MA, Pastan I, Gottesman MM. (2000). FASEB J 14: 516-522.
22. Lee CG, Ren J, Cheong IS, Ban KH, Ooi LL, Yong Tan S et al. (2003). Oncogene 22: 2592-2603.
23. Lee KC, Crowe AJ, Barton MC. (1999). Mol Cell Biol 19: 1279-1288.
24. Levine AJ. (1997). Cell 88: 323-331.
25. Li GQ, Li H, Zhang HF. (2003). World J Gastroenterol 9: 1972-1975.
26. Liu YC, Pan J, Zhang C, Fan W, Collinge M, Bender JR et al. (1999). Proc Natl Acad Sci USA 96: 4313-4318.
27. Luo X, Tang Z, Rizo J, Yu H. (2002). Mol Cell 9: 59-71.
28. Maeda Y, Seidel SD, Wei G, Liu X, Sladek FM. (2002). Mol Endocrinol 16: 402-410.
29. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W et al. (2001). Nature 409: 355-359.
30. Moll UM, Riou G, Levine AJ. (1992). Proc Natl Acad Sci USA 89: 7262-7266.
31. Pagano M. (1997). FASEB J 11: 1067-1075.
32. Pines J. (1994). Nature 371: 742-743.
33. Raasi S, Schmidtke G, de Giuli R, Groettrup M. (1999). Eur J Immunol 29: 4030-4036.
34. Stahler F, Roemer K. (1998). Oncogene 17: 3507-3512.
35. Taylor WR, Schonthal AH, Galante J, Stark GR. (2001). J Biol Chem 276: 1998-2006.
36. Taylor WR, Stark GR. (2001). Oncogene 20: 1803-1815.
37. van den Elsen PJ, Gobin SJ, van Eggermond MC, Peijnenburg A. (1998). Immunogenetics 48: 208-221.
38. Vogelstein B, Lane D, Levine AJ. (2000). Nature 408: 307-310.
39. Vousden KH, Lu X. (2002). Nat Rev Cancer 2: 594-604.
40. Wang X, Jin DY, Ng RW, Feng H, Wong YC, Cheung AL et al. (2002). Cancer Res 62: 1662-1668.
41. Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH et al. (2000). Genes Dev 14: 981-993.